TMO Stock Likely to Gain From New International CorEvitas AD Registry
The latest CorEvitas registry – the company’s 11th independent registry – will allow the prospective evaluation of adolescent AD patients to better understand the disease and the treatment pathway. It ...
Business Wire6d
Thermo Fisher Scientific Launches International CorEvitas Clinical Registry in Adolescent Atopic Dermatitis, a Chronic Skin Condition
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas ...
Nasdaq5d
TMO Stock Likely to Gain From New International CorEvitas AD Registry
Thermo Fisher Scientific TMO announced the launch of the international CorEvitas Adolescent Atopic Dermatitis (AD) Registry, designed to study novel treatments for the most common inflammatory ...
Morningstar7d
Thermo Fisher Scientific Launches International CorEvitas Clinical Registry in Adolescent Atopic Dermatitis, a Chronic Skin Condition
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas Adolescent Atopic Dermatitis (AD) Registry, designed to study novel ...
rheumatologyadvisor2d
High Disease Activity Linked to Increased Risk for Kidney Dysfunction in RA
Higher disease activity is linked to faster eGFR decline and a greater risk for significant kidney dysfunction in RA.
Le Lézard6d
Lipocine to Present at H.C. Wainwright 8th Annual MASH Investor Conference
Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced that it will present and meet with ...